Global In Vivo Preclinical Brain Imaging Devices Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2024 –2030 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
Dollars américains 1,124,983.68 |
 TCAC |
% |
| Principaux acteurs du marché |
>Marché mondial des dispositifs d'imagerie cérébrale préclinique in vivo, par type de modalité d'imagerie (IRM, PET/SPECT, CT, miniscopes optiques, confocale à 2 photons, US, fluorescence NIR, OCT, bioluminescence et autres), application (découverte de médicaments, caractérisation des maladies et toxicologie), domaine thérapeutique ( maladie d'Alzheimer , maladie de Parkinson, oncologie et autres domaines thérapeutiques), variable biologique (BOLD, oxygénation, flux sanguin, microvaisseaux, activité neuronale et tissus mous), format temporel d'utilisation (moins d'une heure, plusieurs heures et longitudinal), utilisateur final (pharma-interne, CRO, milieu universitaire et autres) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et taille du marché des dispositifs d'imagerie cérébrale préclinique in vivo
Le marché mondial des dispositifs d'imagerie cérébrale préclinique in vivo joue un rôle crucial dans l'avancement de notre compréhension du cerveau, des troubles neurologiques et du développement de médicaments. Les dispositifs d'imagerie cérébrale préclinique in vivo fournissent aux chercheurs les outils nécessaires pour étudier la structure et la fonction du cerveau chez les animaux vivants. Cela est fondamental pour faire progresser notre compréhension de la physiologie, de la cognition et du comportement du cerveau. Les sociétés pharmaceutiques et biotechnologiques s'appuient sur l'imagerie cérébrale préclinique pour évaluer l'efficacité et la sécurité de nouveaux médicaments et thérapies ciblant les troubles neurologiques, tels que la maladie d'Alzheimer, la maladie de Parkinson et les troubles psychiatriques.
Data Bridge Market Research analyse que le marché mondial des dispositifs d'imagerie cérébrale préclinique in vivo devrait atteindre la valeur de 1 124 983,68 milliers USD d'ici 2030, à un TCAC de 5,9 % au cours de la période de prévision.
Ce rapport de marché couvre également en profondeur l’analyse des prix et les avancées technologiques.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable de 2015 à 2020) |
|
Unités quantitatives |
Chiffre d'affaires en milliers de dollars américains |
|
Segments couverts |
Type de modalité d'imagerie ( IRM , PET/SPECT, CT, miniscopes optiques, confocal à 2 photons, US, fluorescence NIR, OCT, bioluminescence et autres), application (découverte de médicaments, caractérisation des maladies et toxicologie), domaine thérapeutique (maladie d'Alzheimer, maladie de Parkinson , oncologie et autres domaines thérapeutiques), variable biologique (BOLD, oxygénation, flux sanguin, microvaisseaux, activité neuronale et tissus mous), format temporel d'utilisation (moins d'une heure, plusieurs heures et longitudinal), utilisateur final (pharma-interne, CRO, milieu universitaire et autres) |
|
Pays couverts |
États-Unis, Canada, Mexique, Allemagne, France, Royaume-Uni, Italie, Espagne, Russie, Turquie, Belgique, Pays-Bas, Suisse et reste de l'Europe, Japon, Chine, Corée du Sud, Inde, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines, reste de l'Asie-Pacifique, Brésil, Argentine, reste de l'Amérique du Sud, Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël et reste du Moyen-Orient et de l'Afrique |
|
Acteurs du marché couverts |
PerkinElmer Inc., FUJIFILM Corporation, Mediso Ltd., Spectral Instruments Imaging, MR Solutions, Charles River Laboratories, Aspect Imaging Ltd., Bruker, Miltenyi Biotec, MILabs B.V., and Cubresa Inc. |
Market Definition
In-vivo preclinical brain imaging devices are the tools employed in biomedical research to visualize and study the structure, function, and processes of the brain in living animals, typically rodents, such as mice and rats. These devices play a pivotal role in advancing the understanding of neurobiology, neurological diseases, and the development of potential therapies. They encompass a diverse range of technologies designed to non-invasively capture high-resolution images of the brain, providing researchers with invaluable insights into neural activity and pathology.
Global In Vivo Preclinical Brain Imaging Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Rising Prevalence of Neurological Disorders
The growing prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and various neurodevelopmental disorders, has spurred heightened research efforts. Researchers are driven to better understand the underlying mechanisms, early detection, and potential treatments for these conditions.
There is a growing need for effective diagnostics, treatments, and interventions as the prevalence of neurological disorders continues to rise globally. In-vivo preclinical brain imaging devices are indispensable tools that contribute to a deeper understanding of these disorders and the development of innovative solutions, making them a vital component of the healthcare and research landscape.
Hence, the rising prevalence of neurological disorders is expected to drive the growth of the market in the forecast period.
- Advancements in Imaging Techniques Used in Brain Imaging
Advancements in imaging technologies have led to significantly improved spatial resolution and sensitivity in brain imaging. Higher-resolution images provide researchers with more detailed information about brain structures and functions. This improved clarity is essential for studying fine anatomical details and detecting subtle changes associated with neurological disorders or experimental treatments. Modern preclinical brain imaging devices often offer multi-modal capabilities, allowing researchers to combine multiple imaging techniques in a single study. For instance, combining magnetic resonance imaging (MRI) with positron emission tomography (PET) or single-photon emission computed tomography (SPECT) can provide complementary information about brain structure, metabolism, and function. This versatility enhances the depth and scope of preclinical research.
Advancements in functional brain imaging, such as functional MRI (fMRI) and PET, enable researchers to study brain activity in real time. This is crucial for understanding neural networks, cognitive processes, and how neurological disorders affect brain function. Functional imaging also plays a key role in evaluating the effectiveness of potential therapies. Dynamic imaging techniques, including dynamic contrast-enhanced MRI and dynamic PET, allow researchers to capture changes in brain physiology and function over time. These techniques are valuable for tracking disease progression and assessing the impact of interventions on dynamic processes such as blood flow, metabolism, and neurotransmitter activity.
Hence, advancements in surgical techniques are expected to drive the growth of the market in the forecast period.
Opportunity
Rising Strategic Initiatives by the Key Market Players
The in vivo preclinical brain imaging devices market is witnessing substantial growth due to the proactive strategic initiatives undertaken by the key market players. These initiatives are opening up opportunities for market expansion and advancement.
Strategic partnerships and collaborations between market leaders, academic institutions, research organizations, and pharmaceutical companies foster knowledge sharing and resource pooling. Such collaborations accelerate the development of cutting-edge imaging technologies and enhance the validation of new drug candidates using in vivo brain imaging.
In addition, expanding geographical reach by establishing global subsidiaries and distribution networks makes these devices more accessible to researchers and institutions worldwide. This expansion taps into emerging markets which leads neuroscience research and drug development on the rise.
Furthermore, customization of solutions and services tailored to specific research needs and diversified product portfolios cater to a broader range of customers, driving market growth by addressing diverse research requirements.
Thus, the above-mentioned proactive strategic initiatives by key market players may create opportunities for market growth, making advanced imaging technologies more accessible and precise for researchers and pharmaceutical companies.
Restraint / Challenge
Lack of Skilled Professionals Due to Technology Advancement
The in vivo preclinical brain imaging devices market is a critical segment within the broader field of medical imaging and neuroscience research. These devices play a pivotal role in advancing our understanding of brain function and disorders. However, the market's growth faces a significant challenge due to the scarcity of skilled professionals who can operate and interpret the data generated by these cutting-edge devices.
In-vivo preclinical brain imaging devices are advanced tools that utilize various imaging modalities such as magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) to capture detailed images of the brain in living animals, usually rodents. These images help researchers study brain structure, function, and metabolism, facilitating the development of treatments for neurological disorders, such as Alzheimer's disease, Parkinson's disease, and schizophrenia.
One of the primary reasons why the lack of skilled professionals is a significant challenge for this market is the complexity of the technology involved. Operating and interpreting data from in vivo preclinical brain imaging devices requires a deep understanding of neuroanatomy, imaging physics, and data analysis techniques. Professionals need to be well-versed in the use of specialized software and possess strong analytical skills to make meaningful inferences from the images.
Furthermore, the field of neuroscience and neuroimaging is rapidly evolving, with new techniques and technologies constantly emerging. This necessitates continuous learning and adaptation by professionals to stay at the forefront of the field. As a result, there is a high demand for well-trained individuals who can keep up with the latest advancements and apply them effectively.
Thus, the scarcity of skilled professionals not only limits the adoption of these devices but also potentially hampers the quality of research and development efforts.
Recent Development
- In November 2022, Bruker announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging. This helped the organization develop more revenue.
- In May 2022, FUJIFILM Corporation announced the launch of Vevo F2, the world’s first ultra-high to low frequency (71MHz-1MHz) ultrasound and photoacoustic imaging system for preclinical use. The Vevo F2 features HD image processing technology and introduces a completely new signal pathway – from transducer to display screen. This enabled better image clarity, and when combined with multi-line processing, delivered significantly improved frame rates over earlier generation platforms.
- In April 2022, PerkinElmer, Inc. announced the expansion of its in vivo imaging portfolio with the launch of the Vega imaging system. This increased the company's product portfolio and overall revenue.
- In December 2021, Battery Ventures, a global, technology-focused investment firm, acquired LI-COR Biosciences, an industry-leading company that makes highly engineered instrumentation systems for environmental research, agriculture, drug discovery, protein research, and therapeutics development.
- En octobre 2021, MR Solutions a annoncé le lancement d'une nouvelle IA qui révolutionne l'imagerie par résonance magnétique (IRM) pour la recherche préclinique. Cela a aidé l'organisation à développer davantage de revenus.
Portée du marché mondial des dispositifs d'imagerie cérébrale préclinique in vivo
Le marché mondial des dispositifs d'imagerie cérébrale préclinique in vivo est segmenté en six segments notables en fonction du type de modalité d'imagerie, de l'application, du domaine thérapeutique, de la variable biologique, du format temporel d'utilisation et de l'utilisateur final. La croissance parmi ces segments vous aidera à analyser les segments de croissance maigres dans les industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.
Type de modalité d'imagerie
- IRM
- PET/SPECT
- CT
- Miniscopes optiques
- Confocal à 2 photons
- NOUS
- Fluorescence NIR
- OCTOBRE
- Bioluminescence
- Autres
Sur la base du type de modalité d'imagerie, le marché est segmenté en IRM, PET/SPECT, CT, miniscopes optiques, confocal à 2 photons, US, fluorescence NIR, OCT, bioluminescence et autres.
Application
- Découverte de médicaments
- Caractérisation de la maladie
- Toxicologie
Sur la base des applications, le marché est segmenté en découverte de médicaments, caractérisation des maladies et toxicologie.
Espace thérapeutique
- Maladie d'Alzheimer
- Maladie de Parkinson
- Oncologie
- Autres domaines thérapeutiques
Sur la base du domaine thérapeutique, le marché est segmenté en maladie d'Alzheimer, maladie de Parkinson, oncologie et autres domaines thérapeutiques.
Variable biologique
- AUDACIEUX
- Oxygénation
- Débit sanguin
- Microvaisseaux
- Activité neuronale
- Tissus mous
Sur la base de la variable biologique, le marché est segmenté en BOLD, oxygénation, flux sanguin, microvaisseaux, activité neuronale et tissus mous.
Format temporel d'utilisation
- Moins d'une heure
- De nombreuses heures
- Longitudinal
Sur la base du format temporel d'utilisation, le marché est segmenté en moins d'une heure, plusieurs heures et longitudinal.
Utilisateur final
- Pharma-Interne
- CRO
- Académie
- Autres
Sur la base de l'utilisateur final, le marché est segmenté en sociétés pharmaceutiques internes, CRO, universités et autres.
Analyse/perspectives régionales du marché mondial des dispositifs d'imagerie cérébrale préclinique in vivo
Le marché mondial des dispositifs d’imagerie cérébrale préclinique in vivo est analysé et des informations et tendances sur la taille du marché sont fournies par pays, type de modalité d’imagerie, application, domaine thérapeutique, variable biologique, format temporel d’utilisation et utilisateur final.
Les pays couverts dans ce rapport de marché sont les États-Unis, le Canada, le Mexique, l'Allemagne, la France, le Royaume-Uni, l'Italie, l'Espagne, la Russie, la Turquie, la Belgique, les Pays-Bas, la Suisse et le reste de l'Europe, le Japon, la Chine, la Corée du Sud, l'Inde, l'Australie, Singapour, la Thaïlande, la Malaisie, l'Indonésie, les Philippines, le reste de l'Asie-Pacifique, le Brésil, l'Argentine, le reste de l'Amérique du Sud, l'Afrique du Sud, l'Arabie saoudite, les Émirats arabes unis, l'Égypte, Israël et le reste du Moyen-Orient et de l'Afrique.
L'Amérique du Nord domine le marché avec la plus grande part de marché en raison de la demande croissante d'appareils d'imagerie cérébrale. Les États-Unis sont le pays dominant en Amérique du Nord en raison des avancées technologiques croissantes. L'Allemagne est le pays dominant en Europe en raison de l'adoption croissante des systèmes d'imagerie in vivo. Le Japon est le pays dominant dans la région Asie-Pacifique en raison de la prévalence croissante des troubles neurologiques.
La section par pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques, l'analyse des cinq forces de Porter et les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.
Analyse du paysage concurrentiel et des parts de marché mondiales des dispositifs d'imagerie cérébrale préclinique in vivo
Le paysage concurrentiel du marché mondial des dispositifs d'imagerie cérébrale préclinique in vivo fournit des détails sur le concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.
Certains des principaux acteurs du marché opérant sur le marché sont PerkinElmer Inc., FUJIFILM Corporation, Mediso Ltd., Spectral Instruments Imaging, MR Solutions, Charles River Laboratories, Aspect Imaging Ltd., Bruker, Miltenyi Biotec, MILabs BV et Cubresa Inc., entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 IMAGING MODALITY TYPE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTR’S FIVE FORCES
5 REGULATORY FRAMEWORK
5.1 REGULATORY SCENARIO IN U.S.
5.2 REGULATORY SCENARIO IN AUSTRALIA
5.3 REGULATORY SCENARIO IN EUROPE
5.4 REGULATORY SCENARIO IN SOUTH AFRICA
5.5 REGULATORY SCENARIO IN BRAZIL
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF NEUROLOGICAL DISORDERS
6.1.2 ADVANCEMENTS IN IMAGING TECHNIQUES USED IN BRAIN IMAGING
6.1.3 INCREASING ADOPTION OF IN-VIVO IMAGING SYSTEMS
6.2 RESTRAINTS
6.2.1 ETHICAL AND REGULATORY CONSIDERATIONS
6.2.2 HIGH COST ASSOCIATED WITH BRAIN IMAGING EQUIPMENT
6.3 OPPORTUNITIES
6.3.1 RISING STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS
6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS DUE TO TECHNOLOGY ADVANCEMENT
6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES
7 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE
7.1 OVERVIEW
7.2 MRI
7.3 PET/SPECT
7.4 CT
7.5 OPTICAL MINISCOPES
7.6 2 PHOTON CONFOCAL
7.7 US
7.8 NIR FLUORESCENCE
7.9 OCT
7.1 BIOLUMINESCENCE
7.11 OTHERS
8 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 DRUG DISCOVERY
8.2.1 PRECLINICAL STUDIES
8.2.2 EARLY DRUG DISCOVERY
8.2.3 CLINICAL DEVELOPMENT
8.2.4 POST MARKET MONITORING
8.2.5 DATA REVIEW
8.3 DISEASE CHARACTERIZATION
8.4 TOXICOLOGY
9 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA
9.1 OVERVIEW
9.2 ALZHEIMER'S DISEASE
9.3 PARKINSON'S DISEASE
9.4 ONCOLOGY
9.5 OTHER THERAPEUTIC AREAS
10 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE
10.1 OVERVIEW
10.2 BOLD
10.3 OXYGENATION
10.4 BLOOD FLOW
10.5 MICROVESSELS
10.6 NEURONAL ACTIVITY
10.7 SOFT TISSUE
11 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE
11.1 OVERVIEW
11.2 UNDER AN HOUR
11.3 MANY HOURS
11.4 LONGITUDINAL
12 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER
12.1 OVERVIEW
12.2 PHARMA-INHOUSE
12.3 CRO
12.4 ACADEMIA
12.5 OTHERS
13 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION
13.1 OVERVIEW
13.2 NORTH AMERICA
13.3 EUROPE
13.4 ASIA-PACIFIC
13.5 SOUTH AMERICA
13.6 MIDDLE EAST AND AFRICA
14 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 BRUKER
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 PERKINELMER INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 FUJIFILM CORPORATION
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 MILTENYI BIOTEC
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 CHARLES RIVER LABORATORIES.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 AI4R
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 ASPECT IMAGING LTD.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 BERTHOLD TECHNOLOGIES GMBH & CO.KG
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 CUBRESA INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 HOLOGIC, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 LI-COR, INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 MEDISO LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 MILABS B.V.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 MR SOLUTIONS
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 SPECTRAL INSTRUMENTS IMAGING
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 TRIFOIL IMAGING
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Liste des tableaux
TABLE 1 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 2 GLOBAL MRI IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 3 GLOBAL PET/SPECT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 GLOBAL CT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 5 GLOBAL OPTICAL MINISCOPES IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 6 GLOBAL 2 PHOTON CONFOCAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 GLOBAL US IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 GLOBAL NIR FLUORESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 9 GLOBAL OCT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 GLOBAL BIOLUMINESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 GLOBAL OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 13 GLOBAL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 GLOBAL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 15 GLOBAL DISEASE CHARACTERIZATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 16 GLOBAL TOXICOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 18 GLOBAL ALZHEIMER'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 GLOBAL PARKINSON'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 GLOBAL ONCOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 GLOBAL OTHER THERAPEUTIC AREAS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 23 GLOBAL BOLD IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 GLOBAL OXYGENATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 GLOBAL BLOOD FLOW IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 GLOBAL MICROVESSELS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 GLOBAL NEURONAL ACTIVITY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 GLOBAL SOFT TISSUE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 29 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 30 GLOBAL UNDER AN HOUR IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 31 GLOBAL MANY HOURS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 GLOBAL LONGITUDINAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 34 GLOBAL PHARMA-INHOUSE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 35 GLOBAL CRO IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 36 GLOBAL ACADEMIA IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 GLOBAL OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 38 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 39 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 40 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 41 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 42 NORTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 43 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 44 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 45 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 46 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 47 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 48 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 49 U.S. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 50 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 51 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 52 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 53 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 54 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 55 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 56 CANADA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 57 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 58 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 59 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 60 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 61 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 62 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 63 MEXICO DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 64 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 65 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 66 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 67 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 68 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 69 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 70 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 71 EUROPE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 72 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 73 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 74 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 75 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 76 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 77 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 78 GERMANY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 79 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 80 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 81 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 82 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 83 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 84 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 85 FRANCE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 86 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 87 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 88 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 89 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 90 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 91 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 92 U.K. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 93 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 94 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 95 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 96 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 97 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 98 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 99 ITALY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 100 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 101 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 102 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 103 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 104 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 105 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 106 SPAIN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 107 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 108 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 109 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 110 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 111 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 112 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 113 RUSSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 114 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 115 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 116 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 117 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 118 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 119 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 120 TURKEY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 121 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 122 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 123 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 124 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 125 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 126 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 127 BELGIUM DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 128 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 129 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 130 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 131 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 132 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 133 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 134 NETHERLANDS DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 135 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 136 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 137 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 138 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 139 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 140 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 141 SWITZERLAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 142 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 143 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 144 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 145 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 146 REST OF EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 147 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 148 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 149 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 150 ASIA-PACIFIC DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 151 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 152 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 153 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 154 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 155 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 156 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 157 JAPAN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 158 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 159 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 160 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 161 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 162 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 163 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 164 CHINA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 165 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 166 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 167 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 168 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 169 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 170 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 171 SOUTH KOREA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 172 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 173 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 174 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 175 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 176 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 177 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 178 INDIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 179 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 180 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 181 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 182 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 183 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 184 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 185 AUSTRALIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 186 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 187 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 188 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 189 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 190 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 191 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 192 SINGAPORE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 193 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 194 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 195 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 196 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 197 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 198 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 199 THAILAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 200 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 201 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 202 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 203 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 204 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 205 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 206 MALAYSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 207 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 208 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 209 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 210 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 211 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 212 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 213 INDONESIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 214 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 215 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 216 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 217 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 218 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 219 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 220 PHILIPPINES DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 221 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 222 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 223 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 224 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 225 REST OF ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 226 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 227 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 228 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 229 SOUTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 230 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 231 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 232 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 233 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 234 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 235 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 236 BRAZIL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 237 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 238 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 239 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 240 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 241 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 242 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 243 ARGENTINA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 244 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 245 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 246 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 247 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 248 REST OF SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 249 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 250 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 251 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 252 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 253 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 254 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 255 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 256 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 257 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 258 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 259 SOUTH AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 260 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 261 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 262 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 263 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 264 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 265 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 266 SAUDI ARABIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 267 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 268 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 269 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 270 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 271 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 272 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 273 U.A.E. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 274 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 275 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 276 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 277 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 278 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 279 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 280 EGYPT DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 281 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 282 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 283 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 284 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 285 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 286 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 287 ISRAEL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 288 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 289 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 290 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 291 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 292 REST OF MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
Liste des figures
FIGURE 1 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION
FIGURE 2 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: MARKET END USERS COVERAGE GRID
FIGURE 8 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF NEUROLOGICAL DISORDER IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET FROM 2023 TO 2030
FIGURE 12 IMAGING MODALITY TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET IN 2023 & 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET
FIGURE 16 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY IMAGING MODALITY TYPE, 2022
FIGURE 17 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY APPLICATION, 2022
FIGURE 18 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY THERAPEUTIC AREA, 2022
FIGURE 19 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY BIOLOGICAL VARIABLE, 2022
FIGURE 20 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY TEMPORAL FORMAT OF USE, 2022
FIGURE 21 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY END USER, 2022
FIGURE 22 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SNAPSHOT (2022)
FIGURE 23 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%)
FIGURE 24 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%)
FIGURE 25 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%)
FIGURE 26 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
